Customer Press

MOMENTUM™ Particle Imaging Scanner installed at Karolinska Institutet

A MOMENTUM™ Magnetic Particle Imaging (MPI) Scanner by Magnetic Insight has been installed at the Preclinical Imaging Facility at the Karolinska Institutet in Stockholm, Sweden. The preclinical MOMENTUM scanner produces the world’s highest sensitivity and resolution MPI images.
Read More

Magnetic Insight installs new HYPER localized magnetic theranostic system at Johns Hopkins University

Magnetic Insight has installed a localized magnetic theranostic system at Johns Hopkins University to support an National Institutes of Health-funded project to develop precision-guided magnetic fluid hyperthermia.
Read More

New MOMENTUM Magnetic Particle Imaging Scanner installed at Kennedy Krieger Institute

The first East Coast installation of the MOMENTUM Magnetic Particle Imaging (MPI) scanner has been completed at Kennedy Krieger Institute in Baltimore, MD.
Read More

A World First in Imaging Technology

Monash University has launched world-first technology that can detect magnetic nanoparticles anywhere in the body, enabling enhanced medical applications such as tracking of beneficial CAR-T cells during cancer therapy.
Read More

General Press

Adoptive T Cell Immunotherapy Tracked in Cancer Model Using Magnetic Particle Imaging

The article “Tracking adoptive T cell immunotherapy using magnetic particle imaging” has been published in the journal Nanotheranostics (2021, vol 5.).
Read More

Rising Stars of Magnetic Particle Imaging eSymposium

For the second year, Magnetic Insight has hosted the Rising Stars of Magnetic Particle Imaging eSymposiumto highlight significant research in the field of magnetic particle imaging (MPI).
Read More

Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer

ALAMEDA, Calif., Oct. 14, 2019 /PRNewswire/ — Magnetic Insight, Inc., the leader in Magnetic Particle Imaging (MPI) solutions, announced today that David Panzarella has been appointed as the company’s Chief Commercial Officer.
Read More

Magnetic Insight Introduces MOMENTUM CT, the First Commercial MPI with integrated CT

ALAMEDA, Calif., Sept. 3, 2019 /PRNewswire/ — Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first commercially available MPI system with integrated X-ray computed tomography (CT), offering anatomical context to the newest breakthrough molecular imaging modality. The platform debuts September 3rd, 2019 at the World Molecular Imaging Congress (WMIC) in Montreal, Canada.
Read More

Magnetic Insight Announces Corporate Headquarters Expansion to a State-of-the-Art 22,000 Square-Foot Facility

ALAMEDA, Calif., July 9, 2019 /PRNewswire/ — Magnetic Insight, suppliers of research and diagnostic imaging solutions, announces the completion of their move into a new facility in Alameda, California, to support corporate growth, manufacturing, and R&D infrastructure.
Read More

Magnetic Insight Introduces HYPER, the First Magnetic Particle Imaging (MPI) Based Localized Hyperthermia Platform

ALAMEDA, Calif., March 14, 2019 /PRNewswire/ — Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first localized MPI hyperthermia technology, HYPER, offering millimeter-scale spatial control of magnetic heating for applications in hyperthermia, drug release, and cell activation. The platform debuts in March 2019 at the International Workshop of Magnetic Particle Imaging (IWMPI) in New York and the European Molecular Imaging Meeting (EMIM) in Glasgow, Scotland.
Read More

Grants & NIH

Development of a Commercial Magnetic Particle Imaging Platform for the Detection and Quantification of Localized Inflammation in Cancer

ALAMEDA, Calif., Sept. 30, 2019 /PRNewswire/ — Magnetic Insight, Inc., the leader in Magnetic Particle Imaging (MPI) solutions, announced today that it was awarded a Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health under Award Number R43CA233155. During the twelve-month project, entitled “Development of a commercial Magnetic Particle Imaging platform for the detection and quantification of localized inflammation in cancer,” Magnetic Insight will develop new cancer immunology tools for visualizing inflammation. The project is led by Principal Investigator Patrick Goodwill, Chief Technology Officer of Magnetic Insight.
Read More